• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$22.02 $0.19 (0.87%)

REAL-TIME: Last trade at

Theravance, Inc.

NASDAQ:THRX

Jump to this page for:

Related Resources

Glaxo Hikes Stake in Theravance - Analyst Blog

5/17/2012 by Nasdaq

Seth Klarman Buys More Idenix Pharma, NovaGold, Theravance Inc, Sells Microsoft, BP, Genworth

5/11/2012 by Nasdaq

Revenues Rise at Theravance - Analyst Blog

5/1/2012 by Nasdaq

5 of Last Week's Biggest Winners

4/9/2012 by DailyFinance

The Week's Top Stock Gainers

4/7/2012 by DailyFinance

When Binary Events Become Biotech Bloodbaths

4/4/2012 by DailyFinance

Glaxo to Hike Stake in Theravance - Analyst Blog

4/3/2012 by Nasdaq

Theravance Jumps on Glaxo Investment (THRX, GSK)

4/2/2012 by 247wallst

GlaxoSmithKline To Invest Another $212.887 Million In Theravance

4/2/2012 by Smart Money

CORRECT: US Stocks End At Multiyear Highs On US Manufacturing Report

4/2/2012 by Smart Money

Why Theravance Jumped

4/2/2012 by DailyFinance

Breathe Easy: Program Complete, Data Solid

3/29/2012 by DailyFinance

Mixed Data for Glaxo & THRX Drug - Analyst Blog

3/29/2012 by Nasdaq

Glaxo, Theravance Complete Registrational Program For Relovair

3/23/2012 by Smart Money

Loss Widens at Theravance, Rev Dips - Analyst Blog

2/14/2012 by Nasdaq

Theravance Shares Tanked: What You Need to Know

1/31/2012 by DailyFinance

Investors: 1 Dividend to Buy, 1 Dividend to Sell

1/20/2012 by DailyFinance

Glaxo and Theravance Suffer Setback - Analyst Blog

1/12/2012 by Nasdaq

Glaxo and Theravance Suffer Setback - Analyst Blog

1/12/2012 by Nasdaq

Glaxo Plans Filing Advair Replacement Relovair In Mid-2012

1/9/2012 by Smart Money

CORRECT: Glaxo Plans Filing Advair Replacement Relovair In Mid-2012

1/9/2012 by Smart Money

Theravance Shares Got Crushed: What You Need to Know

1/9/2012 by DailyFinance

Here's What 1 of the Best Investors Is Buying

12/11/2011 by DailyFinance

Risk-Reward Balanced at Theravance - Analyst Blog

12/9/2011 by Nasdaq

Smart Money Picks: Biotech Stocks With Bullish Short Trends

12/8/2011 by DailyFinance

Options Market Picks: 9 Highly Liquid Stocks With Bullish Options Sentiment

11/14/2011 by DailyFinance

GlaxoSmithKline Invests $1.3M In Theravance

11/3/2011 by Smart Money

Smart Money Trends: 5 Biotech Stocks Being Bought Up By Insiders and Institutions

10/5/2011 by Nasdaq

Biotech Exit Rush: Investors Are Freaked Out by Biotech's Hurdles

10/2/2011 by Nasdaq

Here's What Seth Klarman Is Buying

9/7/2011 by DailyFinance

Investing 101: The Top 10 Losers That Have Seen Insider Buying

8/11/2011 by DailyFinance

GlaxoSmithKline Reports Results Of Phase III Studies Of Relovair

6/2/2011 by Smart Money

Glaxo's Advair Replacement Relovair Gets Positive Trial Results

6/2/2011 by Smart Money

Top Picks By Super-Investor Wilbur Ross

5/11/2011 by Seeking Alpha

Top Biotech Picks by Hedge Fund and Mutual Fund Gurus Concentrated in the Sector

5/9/2011 by Seeking Alpha

GlaxoSmithKline Makes $6.7 Million Investment In Theravance

5/4/2011 by Smart Money

How 5 of Yale's Endowment Fund Transactions Are Working Out

5/2/2011 by Seeking Alpha

19 Stocks With Bearish Options Sentiment Releasing Earnings This Week

4/25/2011 by Seeking Alpha

Seth Klarman's Top 10 Holdings: A Brief Analysis

4/25/2011 by Seeking Alpha

Benefit by Imitating Julian Robertson: Bullish on Commodities, China, And Tech

3/30/2011 by Seeking Alpha
See More Articles...